ConductScience.org, home

Paper39447490

Amyloid pathology and cognitive impairment in hAβ-KI and APPSAA-KI mouse models of Alzheimer's disease.

Lu W and 10 others. Neurobiol Aging, 2025. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Amyloid pathology and cognitive impairment in hAβ-KI and APPSAA-KI mouse models of Alzheimer's disease. Papers, record 39447490. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39447490

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Amyloid pathology and cognitive impairment in hAβ-KI and APPSAA-KI mouse models of Alzheimer's disease.
PubMed
Journal
Neurobiol Aging
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
2.11, provisional
iCite
Revised in PubMed
2026-01-02
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lu WWenyan
2Shue FFrancis
3Kurti AAishe
4Jeevaratnam SSuren
5Macyczko JRJesse R
6Roy BBhaskar
7Izhar TTaha
8Wang NNi
9Bu GGuojun
10Kanekiyo TTakahisa
11Li YYonghe

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
Disease Models, AnimalMajor topic
Amyloid beta-PeptidesMajor topic
Mice, TransgenicMajor topic
Amyloid beta-Protein PrecursorMajor topic
Animals
Female
Male
Plaque, Amyloid
Mice
Humans
Brain
Cognition Disorders
Mutation
Homozygote

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AG078615NIA NIH HHSUnited StatesR01AG078615PubMed and NIHNIH RePORTER
R21 AG065653NIA NIH HHSUnited StatesR21AG065653PubMed and NIHNIH RePORTER

Download CSV of grants

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127377630Cognitive deficits in single App knock-in mouse models.Neurobiol Learn Mem2016https://conductscience.org/library/papers/27377630PubMed
237991017Mitochondria-sequestered Aβ renders synaptic mitochondria vulnerable in the elderly with a risk of Alzheimer disease.JCI Insight2023https://conductscience.org/library/papers/37991017PubMed
332024798APOE4 exacerbates α-synuclein pathology and related toxicity independent of amyloid.Sci Transl Med2020https://conductscience.org/library/papers/32024798PubMed
434586832APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia.Sci Transl Med2021https://conductscience.org/library/papers/34586832PubMed
51302033A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid.Nat Genet1992https://conductscience.org/library/papers/1302033PubMed
628768718APP mouse models for Alzheimer's disease preclinical studies.EMBO J2017https://conductscience.org/library/papers/28768718PubMed
732170138Amyloid-β42/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer's disease.Nat Commun2020https://conductscience.org/library/papers/32170138PubMed
824728269Single App knock-in mouse models of Alzheimer's disease.Nat Neurosci2014https://conductscience.org/library/papers/24728269PubMed
911063718Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated A beta(42) in Alzheimer's disease.Hum Mol Genet2000https://conductscience.org/library/papers/11063718PubMed
1020818335Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio.EMBO J2010https://conductscience.org/library/papers/20818335PubMed
1135690868Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia.Mol Neurodegener2022https://conductscience.org/library/papers/35690868PubMed
1218694930The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity.J Biol Chem2008https://conductscience.org/library/papers/18694930PubMed
1329985474Sex differences in Alzheimer disease - the gateway to precision medicine.Nat Rev Neurol2018https://conductscience.org/library/papers/29985474PubMed
1437545238Upregulation of sFRP1 Is More Profound in Female than Male 5xFAD Mice and Positively Associated with Amyloid Pathology.J Alzheimers Dis2023https://conductscience.org/library/papers/37545238PubMed
1524650793Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease.Neurobiol Aging2014https://conductscience.org/library/papers/24650793PubMed
1617046788Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity.J Mol Biol2006https://conductscience.org/library/papers/17046788PubMed
1734366832Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD Study.Front Aging Neurosci2021https://conductscience.org/library/papers/34366832PubMed
1830980041Familial Alzheimer's disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta.Mol Psychiatry2020https://conductscience.org/library/papers/30980041PubMed
1911528419The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.Nat Neurosci2001https://conductscience.org/library/papers/11528419PubMed
2030250265Animal models of neurodegenerative diseases.Nat Neurosci2018https://conductscience.org/library/papers/30250265PubMed

See all 38 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42664049Metabolic Shifts Precede Cognitive Decline in the Male hAß-KI Alzheimer's Mouse Model.FASEB J2026https://conductscience.org/library/papers/42664049PubMed
41913059Glial cytokine modulation improves sleep and circadian disruption in female SAA knock-in mice of Alzheimer's-related pathology.Alzheimers Dement2026https://conductscience.org/library/papers/41913059PubMed
41717780Dim light at night impacts circadian rhythms and Alzheimer's disease-like neuroinflammation and neuropathology in humanized APP SAA knock-in mice.Sleep2026https://conductscience.org/library/papers/41717780PubMed
41256678Dim light at night impacts circadian rhythms and Alzheimer's disease-like neuroinflammation and neuropathology in humanized APP SAA knock-in mice.bioRxiv2025https://conductscience.org/library/papers/41256678PubMed
41000956Characterization of adult hippocampal neurogenesis in the novel App SAA Knock-in Alzheimer's disease mouse model.bioRxiv2025https://conductscience.org/library/papers/41000956PubMed
39920176Longitudinal characterization reveals behavioral impairments in aged APP knock in mouse models.Sci Rep2025https://conductscience.org/library/papers/39920176PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39447490

GET https://conductscience.org/api/papers/v1/39447490/references?page=2